Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Shapiro, Adam B ^a   Gao, Ning ^b   O'Connell, Nichole ^a   Hu, Jun ^a   Thresher, Jason ^a   Gu, Rong Fang ^a   Overman, Ross ^a   Hardern, Ian M ^a   Sproat, Graham G ^a  

^a ASTRAZENECA   (United Kingdom)

^b Reagents and Assay Development Discovery Sciences   (United States)

Author keywords

Fluorescence anisotropy; Nuclear magnetic resonance spectroscopy; Nucleocapsid; Phosphoprotein; Phosphorylation; Protein protein interaction; Respiratory syncytial virus; Surface plasmon resonance

Indexed keywords

ASPARTIC ACID; NUCLEOCAPSID PROTEIN; PHENYLALANINE; SERINE; VIRUS PHOSPHOPROTEIN; NUCLEOPROTEIN; P PROTEIN, HUMAN RESPIRATORY SYNCYTIAL VIRUS; PROTEIN BINDING; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IONIC STRENGTH; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; BINDING SITE; CHEMISTRY; GENETICS; HUMAN; KINETICS; METABOLISM; PHOSPHORYLATION; PROTEIN MOTIF; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS A; RESPIRATORY SYNCYTIAL VIRUS;

AMINO ACID MOTIFS; BINDING SITES; HUMANS; KINETICS; NUCLEOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL STRUCTURAL PROTEINS;

EID: 84935466164     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-014-0191-2     Document Type: Article

References (39)

1. Walsh EE, Falsey AR: Respiratory syncytial virus infection in adult populations. Infect Disord - Drug Targets 2012, 12:98-102.
2. Collins PL, Melero JA: Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 2011, 162:80-99.
3. Najarro P, Angell R, Powell K: The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections. Antivir Chem Chemother 2012, 22:139-150.
4. Meanwell NA, Langley DR: Inhibitors of protein-protein interactions in paramyxovirus fusion: a focus on respiratory syncytial virus. Top Med Chem 2012, 8:167-196.
5. Sudo K, Miyazaki Y, Kojima N, Kobayashi M, Suzuki H, Shintani M, Shimizu Y: YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action. Antiviral Res 2005, 65:125-131.
6. Xiong H, Foulk M, Aschenbrenner L, Fan J, Tiong-Yip CL, Johnson KD, Moustakas D, Fleming PR, Brown DG, Zhang M, Ferguson D, Wu D, Yu Q: Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor. Bioorg Med Chem Lett 2013, 15:6789-6793.
7. Chapman J, Abbott E, Alber DG, Baxter RC, Bithell SK, Henderson EA, Carter MC, Chambers P, Chubb A, Cockerill GS, Collins PL, Dowdell VCL, Keegan SJ, Kelsey RD, Lockyer MJ, Luongo C, Najarro P, Pickles RJ, Simmonds M, Taylor D, Tyms S, Wilson LJ, Powell KL: RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob Agents Chemother 2007, 51:3346-3353.
8. Liuzzi M, Mason SW, Cartier M, Lawetz C, McCollum RS, Dansereau N, Bolger G, Lapeyre N, Gaudette Y, Lagacé L, Massariol M-J, Dô F, Whitehead P, Lamarre L, Scouten E, Bordeleau J, Landry S, Rancourt J, Fazal G, Simoneau B: Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J Virol 2005, 79:13105-13115.
9. Tawar RG, Duquerroy S, Vonrhein C, Varela PF, Damier-Piolle L, Castagné N, MacLellan K, Beouelle H, Bricogne G, Bhella D, Eléouët J-F, Rey FA: Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 2009, 326:1279-1283.
10. El Omari K, Dhaliwal B, Ren J, Abrescia NGA, Lockyer M, Powell KL, Hawkins AR, Stammers DK: Structures of respiratory syncytial virus nucleocapsid protein from two crystal forms: details of potential packing interactions in the native helical form. Acta Cryst F Struct Biol Cryst Commun 2011, 67:1179-1183.
11. Llorente MT, Taylor IA, López-Viñas E, Gomez-Puertas P, Calder LJ, García-Barreno B, Melero JA: Structural properties of the human respiratory syncytial virus P protein: evidence for an elongated homotetrameric molecule that is the smallest orthologue within the family of paramyxovirus polymerase cofactors. Proteins 2008, 72:946-958.
12. Castagné N, Barbier A, Bernard J, Rezaei H, Huet J-C, Henry C, Da Costa B, Eléouët J-F: Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 2004, 85:1643-1653.
13. Galloux M, Tarus B, Blazevic I, Fix J, Duquerroy S, Eléouët J-F: Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial virus. J Virol 2012, 86:8375-8387.
14. García-Barreno B, Delgado T, Melero JA: Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J Virol 1996, 70:801-808.
15. Tran T-L, Castagné N, Bhella D, Varela PF, Bernard J, Chilmoncyk S, Berkenkamp S, Benhamo V, Grznarova K, Grosclaude J, Nespoulos C, Rey FA, Eléouët J-F: The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer. J Gen Virol 2007, 88:196-206.
16. Mason SW, Aberg E, Lawetz C, DeLong R, Whitehead P, Liuzzi M: Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity. J Virol 2003, 77:10670-10676.
17. 2-1 antiterminator: a singular tetramer-tetramer interface arrangement. Biochemistry 2012, 51:8100-8110.
18. Blondot M-L, Dubosclard V, Fix J, Lassoued S, Aumont-Nicaise M, Bontems F, Eléouët J-F, Sizun C: Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein. PLoS Pathog 2012, 8:e1002734.
19. Tran T-L, Castagné N, Dubosclard V, Noinville S, Koch E, Moudjou M, Henry C, Bernard J, Yeo RP, Eléouët J-F: The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol 2009, 83:6363-6374.
20. Asenjo A, Calvo E, Villanueva N: Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J Gen Virol 2006, 87:3637-3642.
21. Khattar SK, Yunus AS, Samal SK: Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P and P-L interactions using a minigenome system. J Gen Virol 2001, 82:775-779.
22. Noton SL, Deflubé LR, Tremaglio CZ, Fearns R: The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter. PLoS Pathog 2012, 8:e1002980.
23. Asenjo A, Mendieta J, Gómez-Puertas P, Villanueva N: Residues in human respiratory syncytial virus P protein that are essential for its activity on RNA viral synthesis. Virus Res 2008, 132:160-173.
24. Tanner SJ, Ariza A, Richard C-A, Kyle HF, Dods RL, Blondot M-L, Wu W, Trincão J, Trinh CH, Hiscox JA, Carroll MW, Silman NJ, Eléouët J-F, Edwards TA, Barr JN: Crystal structure of the essential antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation. Proc Natl Acad Sci U S A 2014, 111:1580-1585.
25. Cartee TL, Wertz GW: Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection. J Virol 2001, 75:12188-12197.
26. 1 motif of the respiratory syncytial virus M2-1 protein is essential for protein function. J Virol 2000, 74:5880-5885.
27. García J, García-Barreno B, Vivo A, Melero JA: Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virol 1993, 195:243-247.
28. Guo W, Wisniewski JA, Haitao J: Hot spot-based design of small-molecule inhibitors for protein-protein interactions. Bioorg Med Chem Lett 2014, 24:2546-2554.
29. 237 as the site of phosphorylation by cellular casein kinase II. Virol 1994, 205:93-103.
30. Mazumder B, Barik S: Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants. Virol 1994, 205:104-111.
31. 237 may play an accessory role. Virol 1995, 213:405-412.
32. Sánchez-Seco MP, Navarro J, Martinez R, Villanueva N: C-terminal phosphorylation of human respiratory syncytial virus P protein occurs mainly at serine residue 232. J Gen Virol 1995, 76:425-430.
33. Villanueva N, Hardy R, Asenjo A, Yu Q, Wertz G: The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential but modulates viral RNA transcription and replication. J Gen Virol 2000, 81:129-133.
34. Lu B, Ma C-H, Brazas R, Jin H: The major phosphorylation sites of respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro. J Virol 2002, 76:10776-10784.
35. El Omari K, Scott K, Dhaliwal B, Ren J, Abrescia NGA, Budworth J, Lockyer M, Powell KL, Hawkins AR, Stammers DK: Crystallization and preliminary X-ray analysis of the human respiratory syncytial virus nucleocapsid protein. Acta Cryst F Struct Biol Cryst Commun 2008, 64:1019-1023.
36. Kleckner IR, Foster MP: An introduction to NMR-based approaches for measuring protein dynamics. Biochim Biophys Acta 1814, 2011:942-968.
37. Pervushin K, Riek R, Wider G, Wüttrich K: Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A 1997, 94:12366-12371.
38. Bradford MM: Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
39. McCall EJ, Danielsson A, Hardern IM, Dartsch C, Hicks R, Wahlberg JM, Abbott WM: Improvements to the throughput of recombinant protein expression in the baculovirus/insect cell system. Protein Express Purif 2005, 42:29-36.